News

Unpacking IonQ's Options Trading Trends and Insights

Unpacking IonQ's Options Trading Trends and Insights

Understanding the Market Sentiment for IonQ

Recent trading activities have shown that financial institutions are exhibiting a noticeable bearish sentiment towards IonQ (NYSE: IONQ). Our in-depth analysis of options trading history has uncovered a total of 54 unusual trades related to this company.

Analyzing Trader Sentiment

Upon closer examination, it's clear that 38% of traders are expressing bullish sentiment towards IonQ, while a larger portion, about 44%, appears to lean bearish. Among the trades we reviewed, 25 were puts, representing a significant monetary value of $2,026,425, whereas 29 calls added up to $1,919,697.

Price Projections from Traders

From the analysis of trading behaviors, it seems that key investors are targeting a price range for IonQ between $30.00 and $110.00 over the past quarter. This range indicates varied expectations about the company's future performance.

Insight into Volume and Open Interest

Examining the volume and open interest is critical when trading options, as this data allows for an assessment of liquidity and trader interest in IonQ’s options at various strike prices. The evolving patterns in volume and open interest for both calls and puts will be discussed in relation to IonQ's notable trades within the $30.00 to $110.00 strike price bracket observed over the last month.

Recent IonQ Option Activity

In the last 30 days, we have seen notable activity in IonQ's options market. The following segment will highlight the largest trades recorded during this time period.

Largest Observed Options Trades

Noteworthy options trades include:

  • Symbol: IONQ, Type: Call, Trade Type: Trade, Sentiment: Bearish, Expected Date: 01/21/28, Ask: $24.1, Bid: $22.4, Price: $23.0, Strike Price: $105.00, Total Price: $299K, Open Interest: 388, Volume: 167
  • Symbol: IONQ, Type: Put, Trade Type: Sweep, Sentiment: Bullish, Expected Date: 11/21/25, Ask: $3.7, Bid: $3.6, Price: $3.6, Strike Price: $50.00, Total Price: $284.7K, Open Interest: 2.5K, Volume: 1.1K
  • Symbol: IONQ, Type: Call, Trade Type: Sweep, Sentiment: Bullish, Expected Date: 01/16/26, Ask: $11.5, Bid: $11.2, Price: $11.5, Strike Price: $70.00, Total Price: $172.5K, Open Interest: 7.4K, Volume: 12
  • Symbol: IONQ, Type: Put, Trade Type: Sweep, Sentiment: Bullish, Expected Date: 04/17/26, Ask: $9.55, Bid: $9.4, Price: $9.4, Strike Price: $50.00, Total Price: $166.3K, Open Interest: 394, Volume: 380
  • Symbol: IONQ, Type: Put, Trade Type: Trade, Sentiment: Bearish, Expected Date: 10/03/25, Ask: $7.0, Bid: $6.45, Price: $7.0, Strike Price: $69.00, Total Price: $140K, Open Interest: 1.1K, Volume: 236

About IonQ

IonQ Inc is at the forefront of quantum computing technology. The company offers access to several quantum computers with varying qubit capacities and is continually advancing its endeavors in the realm of quantum technology. IonQ's quantum computers can be accessed through cloud platforms, promoting a model known as quantum-computing-as-a-service (QCaaS). Their revenue streams include QCaaS arrangements, consulting for algorithm co-development, and projects on custom quantum systems.

Current Market Standing of IonQ

IonQ's stock performance reflects a trading volume of 12,358,565 shares. Currently, the stock price has seen a drop of 3.63%, settling at $61.93. The current relative strength index (RSI) suggests that the stock may be nearing overbought levels, making it essential for investors to stay alert as the next earnings announcement approaches in 36 days.

Analyst Ratings for IonQ

Recently, five market analysts have provided ratings on IonQ, yielding a consensus target price of $74.00. Notably, several analysts have maintained high expectations with specific targets: Cantor Fitzgerald holds a target of $60, while both Benchmark and B. Riley Securities target $75. Moreover, Needham remains optimistic but has adjusted their rating to Buy with a target of $80.

The options trading landscape typically carries a higher risk, but it is also offers potential rewards. Skilled traders tackle these challenges by enhancing their knowledge, refining their strategies, and keeping a constant watch on market trends. For those interested, staying updated with IonQ's ongoing options trading activities is crucial.

Frequently Asked Questions

What has been the recent trend in IonQ's options trading?

IonQ has shown a significant bearish trend among institutional investors along with a mixed sentiment from traders.

What is IonQ's current stock price?

The stock price for IonQ is currently at $61.93, reflecting a decrease of 3.63%.

How many unusual options trades were identified for IonQ?

A total of 54 unusual options trades have been identified, indicating varying sentiment levels among traders.

What is the importance of volume and open interest in options trading?

Volume and open interest are critical indicators for assessing liquidity and trader interest in options at different strike prices.

What is IonQ's business model?

IonQ provides access to quantum computers via cloud platforms and generates revenue through quantum-computing-as-a-service arrangements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 21

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 33

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 344

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 239

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading